NasdaqCM - Nasdaq Real Time Price USD

Enlivex Therapeutics Ltd. (ENLV)

1.0200
-0.0300
(-2.86%)
At close: May 9 at 4:00:00 PM EDT
1.0500
+0.03
+(2.94%)
After hours: May 9 at 4:05:13 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
14,931
14,931
25,151
25,797
19,288
Operating Income
-14,931
-14,931
-25,151
-25,797
-19,288
Net Non Operating Interest Income Expense
1,056
1,056
1,551
821
-208
Other Income Expense
-1,139
-1,139
-5,468
-6,084
5,028
Pretax Income
-15,014
-15,014
-29,068
-31,060
-14,468
Net Income Common Stockholders
-15,014
-15,014
-29,068
-31,060
-14,468
Diluted NI Available to Com Stockholders
-15,014
-15,014
-29,068
-31,060
-14,468
Basic EPS
-0.73
--
-1.56
-1.69
-0.81
Diluted EPS
-0.73
--
-1.56
-1.69
-0.81
Basic Average Shares
20,513.9920
--
18,574.4840
18,394.8860
17,859.7130
Diluted Average Shares
20,513.9920
--
18,574.4840
18,394.8860
17,859.7130
Total Operating Income as Reported
-15,888
-15,888
-29,395
-25,797
-19,288
Total Expenses
14,931
14,931
25,151
25,797
19,288
Net Income from Continuing & Discontinued Operation
-15,014
-15,014
-29,068
-31,060
-14,468
Normalized Income
-13,875
-13,875
-23,600
-24,976
-19,496
Interest Income
1,069
1,069
1,565
835
120
Net Interest Income
1,056
1,056
1,551
821
-208
EBIT
-14,931
-14,931
-25,151
-25,797
-19,288
EBITDA
-14,386
-14,386
-24,316
-25,020
-18,742
Reconciled Depreciation
545
545
835
777
546
Net Income from Continuing Operation Net Minority Interest
-15,014
-15,014
-29,068
-31,060
-14,468
Total Unusual Items Excluding Goodwill
-1,139
-1,139
-5,468
-6,084
5,028
Total Unusual Items
-1,139
-1,139
-5,468
-6,084
5,028
Normalized EBITDA
-13,247
-13,247
-18,848
-18,936
-23,770
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CANF Can-Fite BioPharma Ltd.
1.1100
-0.45%
 
EVGN Evogene Ltd.
1.1325
+0.22%
 
BLRX BioLineRx Ltd.
3.1700
-0.94%
 
PPBT Purple Biotech Ltd
2.2050
-0.68%
 
PLUR Pluri Inc.
5.75
+8.29%
 
ORMP Oramed Pharmaceuticals Inc.
2.2500
-1.75%
 
OVID Ovid Therapeutics Inc.
0.2901
-1.33%
 
ELVN Enliven Therapeutics, Inc.
18.42
-1.13%
 
XBIO Xenetic Biosciences, Inc.
3.0600
-2.86%
 
PYPD PolyPid Ltd.
2.7700
-0.72%